Phosphoric Acid

Phosphoric Acid

SCHEMBL718179

O=C(O)O.O=P(O)(O)O.[CaH2].[SrH2]

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.46
CA1 P00915 1/20 0.46
CA9 Q16790 1/20 0.46
BLM P54132 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.39
KMT2A Q03164 1/20 0.39
SLC34A1 Q06495 1/20 0.33
PEPD P12955 1/20 0.32
MMP2 P08253 2/20 0.31
KDM4E B2RXH2 1/20 0.31
THRB P10828 1/20 0.31
MAPK1 P28482 1/20 0.31
HSD17B10 Q99714 1/20 0.31
FDPS P14324 1/20 0.31
CA4 P22748 1/20 0.30
MMP3 P08254 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid SCHEMBL716900 0.96 CA2 (0.42) CA2CA1CA9BLMTDP1
Phosphoric Acid SCHEMBL285675 0.95 CA2 (0.50) CA2CA1CA9BLMTDP1
Phosphoric Acid SCHEMBL6112781 0.95 CA2 (0.50) CA2CA1CA9BLMTDP1
Phosphoric Acid SCHEMBL9449859 0.95 CA2 (0.50) CA2CA1CA9BLMTDP1
Phosphoric Acid SCHEMBL345048 0.95 CA2 (0.50) CA2CA1CA9BLMTDP1
Phosphoric Acid SCHEMBL28318521 0.95 CA2 (0.50) CA2CA1CA9BLMTDP1
Phosphoric Acid SCHEMBL28048398 0.95 CA2 (0.50) CA2CA1CA9BLMTDP1
Phosphoric Acid SCHEMBL6112776 0.95 CA2 (0.50) CA2CA1CA9BLMTDP1
Phosphoric Acid SCHEMBL9078842 0.95 CA2 (0.50) CA2CA1CA9BLMTDP1
Phosphoric Acid SCHEMBL1615496 0.91 CA2 (0.46) CA2CA1CA9BLMTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110046262-A1 Pasty Insert Material for Widening of Gingival Sulcus and Use Thereof KETTENBACH GMBH & CO. KG (DE) 2011-02-24 US claimed
US-20070218018-A1 SENSITIVITY RELIEF GEL DISCUS DENTAL IMPRESSIONS, INC. (US) 2007-09-20 US claimed
US-5534244-A APPLYING TO TEETH COMPOUNDS WHICH WILL FORM STRONTIUM CONTAINING APATITE, DENTISTRY ADA FOUNDATION 1996-07-09 US claimed
CN-105465639-B LED straight tube lamp 嘉兴山蒲照明电器有限公司 2023-08-01 CN disclosed
CN-111810856-B LED fluorescent lamp 嘉兴山蒲照明电器有限公司 2022-06-14 CN disclosed
CN-106016186-B LED straight lamp 嘉兴山蒲照明电器有限公司 2021-06-01 CN disclosed
CN-106535867-B Oral care formulation system providing amorphous calcium phosphate 皇家飞利浦有限公司 2020-12-25 CN disclosed
CN-111810856-A LED fluorescent lamp 嘉兴山蒲照明电器有限公司 2020-10-23 CN disclosed
CN-106195720-B Lamp cap for LED fluorescent lamp and LED fluorescent lamp 嘉兴山蒲照明电器有限公司 2020-04-07 CN disclosed
US-20200038300-A1 ORAL CARE FORMULATION SYSTEM PROVIDING AMORPHOUS CALCIUM PHOSPHATE KONINKLIJKE PHILIPS NV (NL) 2020-02-06 US disclosed
EP-3166692-B1 ORAL CARE FORMULATION SYSTEM PROVIDING AMORPHOUS CALCIUM PHOSPHATE KONINKLIJKE PHILIPS NV (NL) 2019-11-06 EP disclosed
US-20060115437-A1 Dental whitening compositions DISCUS DENTAL, LLC 2006-06-01 US disclosed
WO-2006053207-A2 DENTAL WHITENING SYSTEMS COMPRISING TRANSITION METAL SALT ACTIVATOR DISCUS DENTAL IMPRESSIONS, INC (US) 2006-05-18 WO disclosed
US-20060099156-A1 Dental whitening compositions DISCUS DENTAL IMPRESSIONS, INC 2006-05-11 US disclosed
US-20060099155-A1 Dental whitening systems DISCUS DENTAL IMPRESSIONS, INC. 2006-05-11 US disclosed
WO-2006014365-A2 DENTAL COMPOSITIONS WITH SENSITIVITY RELIEF DISCUS DENTAL IMPRESSIONS, INC. (US) 2006-02-09 WO disclosed
US-20060008424-A1 Dental compositions with sensitivity relief DEN-MAT HOLDINGS, LLC 2006-01-12 US disclosed
WO-1999025562-A1 LASER MARKING METHOD AND MATERIAL CERDEC CORPORATION (US) 1999-05-27 WO disclosed
US-5534244-A APPLYING TO TEETH COMPOUNDS WHICH WILL FORM STRONTIUM CONTAINING APATITE, DENTISTRY ADA FOUNDATION 1996-07-09 US disclosed
US-5534244-A APPLYING TO TEETH COMPOUNDS WHICH WILL FORM STRONTIUM CONTAINING APATITE, DENTISTRY ADA FOUNDATION 1996-07-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060099155-A1 Dental whitening systems MGST3, GSS, TXN CA2 420/4885CA1 1135/4885CA9 1561/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.